Open in interactive viewer → charts, metric popovers & call review

Tyro Payments: Turning Scale into Cash Flow and Strategic Focus

FY26 results show operating leverage and a clear pivot to cross-selling payments, banking, and health verticals.
TYR.AX · Earnings Call · 2026-08-24

The Shift from Building to Commercializing

Tyro Payments closed FY26 with a clear message: the years of investing in capabilities are giving way to a period of commercializing those investments. CEO Nigel Lee opened the call with “We delivered on our financial guidance strengthened earnings and cash generation and sharpened our focus on the markets where we believe we have the strongest right to win.” — Nigel Lee, Chief Executive Officer (CEO) · 2026-08-24 That focus now sits on four pillars: Health, Banking, Enterprise franchise, and E-commerce. The financials reinforce the narrative: gross profit rose 5.3% to $231.8 million, EBITDA grew 8.6% to $66.9 million (margin expanding to 28.9%), and free cash flow surged 49.5% to $29.4 million. As CFO Emma Burke noted, “Gross profit increased 5.3% to $231.8 million. EBITDA increased 8.6% to $66.9 million, and importantly, free cash flow increased almost 50% to $29.4 million.” — Emma Burke, Chief Financial Officer (CFO) · 2026-08-24 The cash generation story is central: Tyro’s infrastructure, built over years, is now producing outsized cash conversion without proportional investment. The E commerce segment grew 25%, while the focus on Enterprise franchise clients is opening higher-value relationships.

Banking as a Strategic Moat

The most telling evidence of the shift is in banking. Active bank accounts grew 34.6% to 14,500+, and by June, around 34% of new merchants were choosing to bank with Tyro. Emma Burke explained in the Q&A, “That's really a step up from last year to this year, and we're continuing to see greater traction with new account take up on our new merchants currently.” — Emma Burke, Chief Financial Officer (CFO) · 2026-08-24 This matters because merchants who use both payments and banking exhibit materially better retention—more than twice the overall book. The Active bank accounts growth supports a reinforcing flywheel: deposits rose 27.3% to $118.9 million, which in turn funds loan originations, up 19.4% to $187.8 million. The deep integration between payments and banking is a differentiator that larger competitors struggle to replicate. Nigel Lee highlighted that larger merchants value "local expertise, deep integration, reliable service, and increasingly seamless propositions across channels."

Regulatory Tailwinds and the Path Forward

A major catalyst is the RBA’s elimination of card surcharging effective October 1. Tyro sees this as a leveling of the playing field, given its low exposure to no-cost EFTPOS. Nigel Lee framed it as an opportunity: "we see a great opportunity for us to be able to continue to explain and provide options to merchants to allow them to be able to grow through that change." The company has already factored the impact into FY27 guidance, which projects normalized gross profit of $240–255 million and an EBITDA margin of 28.5–30.5%. The bulk billing headwind in Health, which moderated growth last year, is expected to cycle by November, with Health volumes returning to historical growth rates. Meanwhile, Allied Health grew 26% and Dental 19%, showing the vertical playbook is working.

We started to see the shift from building capability to commercializing it in FY '26. In FY '27, our focus is on accelerating that shift.

The company enters FY27 with a strong balance sheet—$145 million in available owned funds and a total capital ratio of 76.5%. This gives it flexibility to invest in high-conviction organic opportunities and consider capital returns to shareholders. Tyro’s narrative is no longer about potential; it’s about compounding.